MMI Investments

Medical Microinstruments (MMI) is a pioneering medical technology company focused on enhancing the capabilities of surgeons performing complex microsurgical procedures. The company's flagship product, the Symani Surgical System, is a robotic platform equipped with the world's smallest wristed microinstruments, designed to mimic the natural dexterity of the human hand at a microscopic scale. By providing tremor filtration and motion scaling, the system enables high-precision suturing of delicate vessels and nerves, which is critical in fields such as lymphatic surgery, trauma replantation, and oncology reconstruction. MMI recently secured $110 million in Series C financing to accelerate the global commercial rollout of Symani and expand its clinical evidence base. The company is headquartered in Jacksonville, Florida, with its primary research and development operations located in Pisa, Italy.